Once dissolved, store the solution at 2C8C and use within 2030 days for optimal research consistency
Jeong HG, Cho S, Ryu KJ, Kim T, Park H
The approval is supported by results from the Phase 3 POETYK PsA1 and POETYK PsA2 trials, which demonstrated statistically significant improvements in ACR20 Response and other key disease outcomes compared with placebo, while maintaining a safety profile consistent with earlier studies
Trends in Pharmacological Sciences, 46 (2), 101112
The latest results follow positive Phase III data from TRIUMPH-1 and TRIUMPH-4 , which evaluated retatrutide in other obesity populations and complications
What to do if you are on a GLP-1 and want to keep muscle If you are taking a GLP-1 medication and worried about muscle loss, the answer is structure